eMarketer principal analyst Mark Dolliver, junior analyst Blake Droesch, and vice president of content studio at Insider Intelligence Paul Verna discuss the we-used-to-share-things economy, Amazon's new online pharmacy, Twitter keeping some election tactics, the sudden surge in disappearing messages, the share of Facebook content that's political, why movie previews are called "trailers," and more.
Today marks a big milestone at Insider Intelligence: We launched our new platform, unifying our two brands (eMarketer and Business Insider Intelligence) into a single online experience and expanded our Financial Services coverage. We also just published a report that’s been long in the making--and it happens to be our very first under the new brand.
Business Insider Intelligence research analyst Daniel Keyes and eMarketer principal analyst at Insider Intelligence Andrew Lipsman discuss how Amazon tripled its revenues during an economic recession. They then talk about how Pinterest posted such strong Q3 growth, Walmart converting some stores into ecommerce labs, and Under Armour selling its smartphone app MyFitnessPal.
Earlier this month, Mucinex unveiled Sickwear, a six-piece fashion collection that aims to help consumers get through the cold and flu season in style. While it may not be the typical route for a healthcare brand, its parent company RB has been leveraging different channels, including TikTok and now social commerce, to reach consumers—particularly those who may not be aware of its direct-to-consumer (D2C) business.
In a challenging year for advertising worldwide, Germany will experience a slowdown similar to that of every other market we track. Germany’s digital ad spending had grown at double-digit rates for each of the past three years, but pandemic-disrupted 2020 will see that growth slow to just 0.8%.
The healthcare and pharma industry is one of the only US industries to significantly increase its digital ad spend this year.
The healthcare and pharma industry has been slower to embrace digital marketing compared with other verticals we track. Heavy regulation makes ad targeting more difficult, which has kept traditional media buys and in-person marketing popular.
Despite general pullback in digital ad spending across many industries this year, the healthcare and pharma industry will increase its digital ad spend by 14.2% to reach $9.53 billion. This will make it the fastest-growing industry after computing products and consumer electronics, we forecast.